Cesium carbonate → (4-(5-((1R,2S)-2-amino-1-phenylpropoxy)-1H-indazol-1-yl)phenyl)methanol
反応式
I[C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[N:7]([C:11]1[CH:16]=[CH:15][C:14]([CH2:17][OH:18])=[CH:13][CH:12]=1)[N:6]=[CH:5]2.[C:19](=[O:22])([O-])[O-].[Cs+].[Cs+]>C(#N)CCC.[Cu]I>[NH2:6][C@@H:5]([CH3:4])[C@@H:19]([C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)[O:22][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[N:7]([C:11]1[CH:16]=[CH:15][C:14]([CH2:17][OH:18])=[CH:13][CH:12]=1)[N:6]=[CH:5]2参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
実験手順
(4-(5-iodo-1H-indazol-1-yl)phenyl)methanol (141b, 1.06 g, 3 mmol), (2R,3S-norephedrine (1.39 g, 9.2 mmol), CuI (206 mg, 1 mmol) and was stirred under argon atmosphere in butyronitrile (14 mL) at 125° C. Caesium carbonate (5.1 g, 15.7 mmol) was added and the mixture was vigorously stirred for 50 min, cooled, filtered and evaporated. Chromatography (SiO2, 040% MeOH in EtOAc) afforded (4-(5-((1R,2S)-2-amino-1-phenylpropoxy)-1H-indazol-1-yl)phenyl)methanol (516 mg, 45%).
後処理
- temperaturecooled
- filtrationfiltered
- customevaporated
出典と根拠
- ORDレコード
- ord-885797438cc045759339826c3a6a2f8e
- 出典データセット
- uspto-grants-2012_03
- 特許番号
- US08143290B2
反応ノート
読み込み中…